Prednisolone
Active ingredient · 11 therapeutic classes
- Drug class
- Corticosteroids Acting Locally
- Availability
- Prescription only
- Routes
- Ophthalmic, Oral
- Markets covered
- 3
- Products on record
- 78
- FDA reports (12 mo)
- 11,069
Overview
Prednisolone is an active pharmaceutical ingredient in the Corticosteroids Acting Locally group (A07EA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 70 | May 22, 2026 |
| US United States | FDA | 7 | April 24, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
GBUnited Kingdom· MHRA
70 products
Uses
Allergy and anaphylaxis:
Bronchial asthma, drug hypersensitivity reactions, serum sickness, angioneurotic oedema, anaphylaxis, incapacitating allergies unresponsive to conventional treatment.
Arteritis/collagenosis:
Giant cell arteritis/polymyalgia rheumatica, mixed connective tissue disease, polyarteritis nodosa, polymyositis.
Blood disorders:
Haemolytic anaemia (auto-immune), leukaemia (acute and chronic lymphocytic), lymphoma, multiple myeloma, idiopathic thrombocytopenic purpura Cardiovascular disorders: Post-myocardial infarction syndrome, rheumatic fever with severe carditis Endocrine disorders: Primary and secondary adrenal insufficiency, congenital adrenal hyperplasia Gastro-intestinal disorders: regional ileitis, (Crohn's disease), ulcerative colitis, persistent coeliac syndrome (celiac disease unresponsive to gluten withdrawal), auto- immune chronic active hepatitis, multisystem disease affecting liver, biliary peritonitis Hypercalcaemia: Sarcoidosis, vitamin D excess Infections (with appropriate chemotherapy): Helminthic infestations, Herxheimer reaction, infectious mononucleosis, miliary tuberculosis, mumps orchitis (adult), tuberculous meningitis, rickettsial disease Muscular disorders: Polymyositis, dermatomyositis, Bell’s palsy Neurological disorders: Infantile spasms, Shy-Drager syndrome, sub-acute demyelinating polyneuropathy Ocular disease: Scleritis, posterior uveitis, retinal vasculitis, pseudo-tumours of the orbit, giant cell arteritis, malignant ophthalmic Graves disease Renal disorders: Lupus nephritis, acute interstitial nephritis, minimal change glomerulonephritis, nephrotic syndrome Respiratory disease: Allergic pneumonitis, asthma, occupational asthma, pulmonary aspergillosis, pulmonary fibrosis, pulmonary alveolitis, aspiration of foreign body, aspiration of stomach contents, pulmonary sarcoid, drug- induced lung disease, adult respiratory distress syndrome, spasmodic croup, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculosis chemotherapy Rheumatic disorders: Rheumatoid arthritis, polymyalgia rheumatica, juvenile chronic arthritis, systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease, and psoriatic arthritis Skin disorders: Pemphigus vulgaris, exfoliative dermatitis, bullous pemphigoid, systemic lupus erythematosus, pyoderma gangrenosum Miscellaneous: Sarcoidosis, hyperpyrexia, Behçets disease, immunosuppression in organ transplantation.
USUnited States· FDA
7 products
Uses
INDICATIONS AND USAGE
Prednisolone acetate ophthalmic suspension 1% is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
How to take
CACanada· Health Canada
1 product
Uses
Management of conditions known to be responsive to prednisone or prednisolone where anti-inflammatory action or immunosuppression or adrenocortical supplementation and replacement is required. For most indications, glucocorticoid administration provides symptomatic relief, but has no effect on the underlying disease processes.
Use of these medications does not eliminate the need for other therapies that may be required. 1 Pediatrics pms-PREDNISOLONE oral solution is appropriate for pediatric usage and for those patients with difficulty swallowing solid oral dosage forms.
How to take
Drug interactions
Known interactions involving Prednisolone. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL429760065 · revised September 27, 2024
- [2]FDA DailyMed · 02fc6f0b-d053-49… · revised April 24, 2026 [PDF]
- [3]Health Canada (DPD) · 02245532 · revised March 22, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.